Weekly Top Ten News Stories – 4 September 2020

The Chartist reports a2 Milk is in a downtrend that may provide a good entry point, but likely not yet.

The uranium price continues its slide as nuclear plant decommissions in the US and Scotland are planned.

Dear time-conscious investor: High PE stocks continue to benefit most this month, while one expert is calling for the next commodities supercycleIn this week’s Weekly Insights:-August Reporting Favours Quality & Growth-Morgans Model portfolios-The Next C

NextDC is one of the few businesses benefiting from accelerated demand resulting from the pandemic, although the longer-term outlook is also robust.

Peter Switzer of the Switzer Report has asked seven investment experts (himself included) to each pick one investment choice.

Competition in the Buy Now Pay Later market is accelerating, as rivals are attracted to the economics generated by first mover Afterpay. How well can the two local providers withstand the onslaught?

Lendlease has outlined a welcome strategy to ramp up earnings from development and investment while simplifying its business. However, uncertainties continue.

With biotechnology in focus in 2020, Race Oncology is attracting investor interest

The New Criterion's Tim Boreham notes increasing interest in data centre stocks, large and small, due to the virus and cyber attacks.

Weekly update on stockbroker recommendation, target price, and earnings forecast changes.